Evidence map›Paper›PMID 24446451›Full record

ArticleThe Journal of biological chemistry2014

Benzothiazinones mediate killing of Corynebacterineae by blocking decaprenyl phosphate recycling involved in cell wall biosynthesis.

Shipra Grover, Luke J Alderwick, Arun K Mishra, Karin Krumbach, Jan Marienhagen, Lothar Eggeling, Apoorva Bhatt, Gurdyal S Besra

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Top five unanswered questions in bacterial cell wall research.Cell surface (Amsterdam, Netherlands) · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Molecular Mechanisms of MmpL3 Function and Inhibition.Microbial drug resistance (Larchmont, N.Y.) · 2023
    Review
  9. Article
  10. Article
  11. Bacterial Cell Wall Modification with a Glycolipid Substrate.Journal of the American Chemical Society · 2019
    Article
  12. Metabolism Shapes the Cell.Journal of bacteriology · 2017
    Review
  13. Article
  14. Article
  15. Membrane remodelling in bacteria.Journal of structural biology · 2016
    Review
  16. Article
  17. Article
  18. Article
  19. The Mycobacterial Cell Wall--Peptidoglycan and Arabinogalactan.Cold Spring Harbor perspectives in medicine · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Shipra GroverFrom the School of Biosciences, Institute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom and.
Luke J Alderwick
Arun K Mishra
Karin Krumbach
Jan Marienhagen
Lothar Eggeling
Apoorva Bhatt
Gurdyal S Besra
University of Birmingham · GBForschungszentrum Jülich · DE

Funding

Medical Research Council MR/K012118/1Wellcome TrustWellcome Trust 081569/Z/06/Z
6 · The paper itself

Abstract

Benzothiazinones (BTZs) are a new class of sulfur containing heterocyclic compounds that target DprE1, an oxidoreductase involved in the epimerization of decaprenyl-phosphoribose (DPR) to decaprenyl-phosphoarabinose (DPA) in the Corynebacterineae, such as Corynebacterium glutamicum and Mycobacterium tuberculosis. As a result, BTZ inhibition leads to inhibition of cell wall arabinan biosynthesis. Previous studies have demonstrated the essentiality of dprE1. In contrast, Cg-UbiA a ribosyltransferase, which catalyzes the first step of DPR biosynthesis prior to DprE1, when genetically disrupted, produced a viable mutant, suggesting that although BTZ biochemically targets DprE1, killing also occurs through chemical synthetic lethality, presumably through the lack of decaprenyl phosphate recycling. To test this hypothesis, a derivative of BTZ, BTZ043, was examined in detail against C. glutamicum and C. glutamicum::ubiA. The wild type strain was sensitive to BTZ043; however, C. glutamicum::ubiA was found to be resistant, despite possessing a functional DprE1. When the gene encoding C. glutamicum Z-decaprenyl-diphosphate synthase (NCgl2203) was overexpressed in wild type C. glutamicum, resistance to BTZ043 was further increased. This data demonstrates that in the presence of BTZ, the bacilli accumulate DPR and fail to recycle decaprenyl phosphate, which results in the depletion of decaprenyl phosphate and ultimately leads to cell death.

Indexed as

Alcohol OxidoreductasesBacterial ProteinsCorynebacterium glutamicumEnzyme InhibitorsMycobacterium tuberculosisOxidoreductasesPolyisoprenyl PhosphatesSpiro CompoundsThiazines2-(2-methyl-1,4-dioxa-8-azaspiro(4.5)dec-8-yl)-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-oneAlcohol OxidoreductasesBacterial Proteinsdecaprenyl phosphateDprE1 protein, Mycobacterium tuberculosisEnzyme InhibitorsOxidoreductasesPolyisoprenyl PhosphatesSpiro CompoundsThiazinesBacterial MetabolismCarbohydrate MetabolismCell WallDrug ResistancePolysaccharide

Identifiers

PMID24446451
PMCPMC3937683
OpenAlexW2000524616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.